Newsletter Signup | Join Community
77
IMAB362 precision medicine targets the CLDN18.2 protein in gastric cancer and appears to improve survival.
Treatment of stage IV gastric cancer consists of surgery & systemic chemotherapy and newer precision cancer medicines.
HER2 targeted therapy improves outcome of HER2-positive stomach cancer and patients should undergo HER2 testing
Surgery is the primary treatment for stages 0 & I gastric cancer
Keytruda immunotherapy improves outcomes in PD-L1 positive gastric cancer.
Lonsurf represents a new treatment option for gastroesophageal junction and gastric cancer.
Stay Current With Gastric Cancer Treatment Advances & Connect with Others
